Paid Clinical Trials in Loveland, CO
As of August 2026, 58 paid clinical trials are recruiting in Loveland, Colorado. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Loveland offers studies at sites including Medical Center of the Rockies for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Ovarian Carcinoma, Stage IV Lung Cancer AJCC v8, Advanced Esophageal Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Loveland
Trials by drug in Loveland
Filter results
56 clinical trials
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Prevail Global Study
J-Valve Transfemoral Pivotal Study
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
PARTNER 3 Trial - Aortic Valve-in-Valve
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Hydrus® Microstent New Enrollment Post-Approval Study
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Top Research Study Locations in Loveland
Researchers run research studies in Loveland, CO at 17 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Medical Center of the Rockies | Anatomic Stage II Breast Cancer AJCC v8, Ovarian Carcinoma, Stage IV Lung Cancer AJCC v8 | 40 |
| UC Health Medical Center of the Rockies | Aortic Valve Stenosis, ARDS, Aortic Stenosis, Calcific | 3 |
| UCHealth - Medical Center of the Rockies | Multiple Myeloma, Motivational Factors for Nurse Retention, Nurse Well-being | 3 |
| Banner MD Anderson Cancer Center at McKee Medical Center | Breast Neoplasms, Neoplasm Metastasis | 2 |
| Banner MD Anderson Cancer Center at North Colorado Medical Center | Non-Small Cell Lung Cancer | 1 |
| Banner MD Anderson Northern Colorado | Breast Cancer | 1 |
| Banner North Colorado Medical Center - Loveland Campus | Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Eye Center of Northern Colorado | Primary Open Angle Glaucoma | 1 |
| McKee Medical Center | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| UC Health Northern Colorado (Medical Center of the Rockies) | Aortic Valve Disease Mixed, Aortic Valve Regurgitation | 1 |
| UC Health Northern Colorado/Medical Center of the Rockies | Aortic Stenosis, Aortic Stenosis, Severe | 1 |
| UCHealth Family Medicine - North Loveland | Obesity | 1 |
| UCHealth Internal Medicine - East Loveland | Obesity | 1 |
| UCHealth Internal Medicine - Orchards | Obesity | 1 |
| UCHealth Medical Center of the Rockies | Hypertension, Hypertension, Essential, Hypertension, Systolic | 1 |
| UCHealth Orchards Medical Center | Obesity | 1 |
Active & Upcoming Studies in Loveland (2026)
Recruiting trials in Loveland grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (42 active studies)
- Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial · Phase 3 · NRG Oncology
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
Cardiovascular (2 active studies)
- Prevail Global Study · Medtronic Vascular
- BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT · Orchestra BioMed, Inc
Diabetes & metabolic (1 active study)
- PATHWEIGH: Pragmatic Weight Management in Primary Care · University of Colorado, Denver
Neurology & pain (1 active study)
Eye & vision (1 active study)
- Hydrus® Microstent New Enrollment Post-Approval Study · Alcon Research
Common conditions studied in Loveland
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Ovarian Carcinoma (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
- Advanced Esophageal Adenocarcinoma (2 active studies)
- Advanced Gastric Adenocarcinoma (2 active studies)
- Advanced Gastroesophageal Junction Adenocarcinoma (2 active studies)
Leading research sponsors in Loveland
- National Cancer Institute (NCI)
- NRG Oncology
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Edwards Lifesciences
Frequently asked questions
How many paid clinical trials are currently recruiting in Loveland?
There are approximately 58 recruiting clinical trials in Loveland, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Loveland pay participants?
Most recruiting trials in Loveland compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Loveland?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Loveland?
The most common conditions under active study in Loveland include Anatomic Stage II Breast Cancer AJCC v8 (3), Ovarian Carcinoma (3), Stage IV Lung Cancer AJCC v8 (3), Advanced Esophageal Adenocarcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Loveland?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Loveland on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Loveland?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Loveland?
Recruiting research sites in Loveland include Medical Center of the Rockies, UC Health Medical Center of the Rockies, UCHealth - Medical Center of the Rockies, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Loveland right now?
The largest active categories in Loveland are Cancer & tumors (42), Cardiovascular (2), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.